Skip to main content
. 2022 Apr 28;41:344. doi: 10.11604/pamj.2022.41.344.23664

Table 4.

association between participant characteristics and HRQoL

Characteristics Good [Frequency %)] Intermediate/poor [Frequency (%)] OR [95% CI] P value
Age Group (years) 56 (75.7) 18 (24.3) 2.40
13-18 22 (56.4) 17 (43.7) [1.05-5.49]
8-12 0.00009
Gender 51 (85.0) 9 (15.0) 5.46
Male 27 (50.9) 26 (41.1) [2.24-13.29]
Female 0.554
Primary caregiver 71 (68.3) 33 (31.7) 0.61
≥ One parent � 7 (77.8) 2 (22.2) [0.12-3.12]
Non- Parent 0.680
ART regimen 23 (71.9) 9 (28.1) 1.21
Second line 55 (67.9) 26 (32.1) [0.49-2.97]
First line 0.0032
ART duration 72 (74.2) 25 (25.8) 4.80
>60 months 6 (37.5) 10 (62.5) [1.58-14.56]
≤60 months 0.436
CD4 count cells/μL 63 (70.8) 26 (29.2) 1.45
≥500 15 (62.5) 9 (37.5) [0.57-3.74]
<500 2.20 0.102
Viral load (copies/ml) 66 (72.5) 25 (27.5) [0.85-5.73]
<1000 12 (54.5) 10 (45.5)
≥1000
Multivariate analysis of participant characteristics and good HRQoL B OR 95% CI p-value
Characteristic
Age group 0.192 1.212 1.029-1.428 0.002
13-18 years
Gender -1.744 0.175 0.067-0.455 0.001
Male
Duration on ART -1.802 0.165 0.044-0.620 0.008